Breaking the Fda Monopoly

3 Pages Posted: 25 Jul 2004

See all articles by Bartley J. Madden

Bartley J. Madden

Center for Advancing Corporate Performance

Abstract

I propose to end the FDA monopoly on market access to drugs and medical devices. I believe a "second track" could be opened for consumers to access those products - a track that would allow informed consumers to purchase drugs that have undergone only the first phase of the three-phase FDA drug-approval process. By opening this second track, patients would have access to potential miracle drugs after those drugs have passed their Phase I safety tests, while the FDA could continue the Phases II and III tests that examine the drug's efficiency.

Keywords: FDA, Food and Drug Administration, health, medicine, drug-approval, prescription drugs, health care, health care market, clinical trials

JEL Classification: O38, I11, I18

Suggested Citation

Madden, Bartley J., Breaking the Fda Monopoly. Available at SSRN: https://ssrn.com/abstract=568404

Bartley J. Madden (Contact Author)

Center for Advancing Corporate Performance ( email )

565 West Adams
Chicago, IL 60661
United States

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
94
Abstract Views
1,289
rank
309,295
PlumX Metrics